SCHEMBL5068263

SCHEMBL5068263

COc1cc2ncsc2cc1C(=O)O

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 8/20 0.47
NPC1 O15118 4/20 0.47
RAB9A P51151 4/20 0.47
L3MBTL1 Q9Y468 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
HKDC1 Q2TB90 1/20 0.47
ALDH1A1 P00352 6/20 0.45
HPGD P15428 3/20 0.45
LCK P06239 1/20 0.44
FYN P06241 1/20 0.44
LMNA P02545 3/20 0.42
MAPT P10636 2/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
MEN1 O00255 3/20 0.41
KMT2A Q03164 3/20 0.41
POLB P06746 1/20 0.41
HSD17B10 Q99714 1/20 0.41
PTK6 Q13882 1/20 0.40
NPSR1 Q6W5P4 1/20 0.38
DAO P14920 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30438266 1.00 KDM4E (0.47) KDM4ENPC1RAB9AL3MBTL1TDP1
SCHEMBL8980162 0.94 KDM4E (0.47) KDM4ENPC1RAB9AL3MBTL1TDP1
SCHEMBL4420731 0.81 NPC1 (0.58) KDM4ENPC1RAB9AL3MBTL1TDP1
SCHEMBL28922177 0.81 GAA (0.49) KDM4ENPC1RAB9AL3MBTL1TDP1
SCHEMBL927420 0.79 PTK6 (0.41) KDM4ENPC1RAB9AL3MBTL1TDP1
SCHEMBL30702433 0.79 PTK6 (0.41) KDM4ENPC1RAB9AL3MBTL1TDP1
SCHEMBL8980355 0.79 TSHR (0.49) KDM4ENPC1RAB9AL3MBTL1TDP1
SCHEMBL30251624 0.79 NPC1 (0.56) KDM4ENPC1RAB9AL3MBTL1TDP1
SCHEMBL8980221 0.79 NPC1 (0.56) KDM4ENPC1RAB9AL3MBTL1TDP1
SCHEMBL352444 0.77 NPC1 (0.53) KDM4ENPC1RAB9AL3MBTL1TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7345180-B2 Compound inhibiting dipeptidyl peptidase IV SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 2008-03-18 US disclosed
US-20060229286-A1 Compound inhibiting dipeptidyl peptidase IV SANWA KAGAKU KENKYUSHO CO., LTD. (JP) 2006-10-12 US disclosed
EP-1595866-A1 COMPOUND INHIBITING DIPEPTIDYL PEPTIDASE IV Sanwa Kagaku Kenkyusho Co., Ltd. (JP) 2005-11-16 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060229286-A1 Compound inhibiting dipeptidyl peptidase IV DPP4, DPP3, DPP7 KDM4E 2352/4885NPC1 371/4885RAB9A 3667/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.